Borrelia: Relapsing Fever Pathogens

Borrelia bacteria are spiral-shaped microorganisms that cause distinct diseases in humans, from recurring fevers that can leave patients bedbound for days to painful oral infections that make eating nearly impossible. These spirochetes have evolved unique strategies to evade the immune system, making them particularly challenging pathogens. Understanding these bacteria is essential for healthcare providers, especially since their clinical presentations can mimic other common conditions.

What makes Borrelia bacteria unique? 🔗

Borrelia belong to a group of bacteria called spirochetes, characterized by their distinctive corkscrew shape. These thin, flexible bacteria measure 8-30 micrometers in length and possess flagella that run between their outer and inner membranes. This structural arrangement gives them remarkable mobility through viscous environments like blood and tissue fluid.

Unlike typical bacteria, Borrelia are challenging to visualize with standard Gram staining. Although technically Gram-negative, they stain poorly with conventional methods and are best identified using specialized aniline dyes like Giemsa or Wright stains. This unique characteristic often requires laboratory personnel with specific expertise to recognize these organisms under the microscope.

Borrelia recurrentis and relapsing fever 🔗

Borrelia recurrentis causes louse-borne relapsing fever, one of the most severe forms of Borrelia infection. This disease earned its name from the characteristic pattern of recurring fever episodes that patients experience, each separated by periods of feeling relatively well.

How transmission occurs 🔗

Unlike many vector-borne diseases, B. recurrentis spreads through a unique mechanism involving the human body louse. The bacteria don’t transmit through the louse’s bite directly. Instead, transmission occurs when an infected louse is crushed against the skin, usually during scratching. The bacteria present in the louse’s body cavity then penetrate through broken skin or mucous membranes.

Humans serve as the only known reservoir for B. recurrentis, meaning the bacteria cycle exclusively between people and lice. This human-specific transmission pattern explains why outbreaks typically occur in overcrowded conditions with poor access to hygiene facilities, such as refugee camps, areas experiencing conflict, or regions affected by natural disasters.

Clinical presentation of epidemic relapsing fever 🔗

After an incubation period of 4 to 18 days following exposure, patients develop sudden onset of high fever, often accompanied by intense chills, severe headache, muscle aches, and joint pain. The initial febrile episode typically lasts about one week and can be quite severe.

The hallmark of this disease is its relapsing pattern. After the first fever resolves, patients experience several recurrences of shorter and less severe episodes, typically occurring every 5 to 10 days. Most patients with epidemic relapsing fever experience 1 to 2 relapses, though some may have more episodes before complete recovery.

During acute episodes, patients often develop hepatic tenderness, enlargement of the liver and spleen, and may experience bleeding manifestations such as nosebleeds or subconjunctival hemorrhage. The disease can affect multiple organ systems, potentially leading to complications including myocarditis, acute respiratory distress, and neurological involvement.

Understanding the relapse phenomenon 🔗

The recurring nature of relapsing fever stems from a remarkable survival strategy employed by Borrelia bacteria. These organisms can alter the proteins expressed on their outer surface through a process called antigenic variation. When the immune system develops antibodies against one set of surface proteins, the bacteria undergo genetic changes to express completely different surface proteins.

This constant shifting allows the bacteria to escape immune detection repeatedly, leading to cycles of bacterial multiplication and immune response. Each relapse represents a new wave of bacteria expressing different surface proteins that the immune system hasn’t yet recognized. This ability to evade immunity makes infection clearance challenging and prevents long-term protective immunity.

Borrelia vincentii and oral infections 🔗

While B. recurrentis causes systemic disease, Borrelia vincentii represents a completely different clinical scenario. This spirochete normally resides in the human oral cavity as part of the regular microbial community, particularly in the gingival crevices around teeth.

From commensal to pathogen 🔗

Under normal circumstances, B. vincentii coexists peacefully with other oral bacteria and the host immune system. However, certain conditions can disrupt this delicate balance, allowing the bacteria to proliferate excessively and cause disease. Contributing factors include poor oral hygiene, immunosuppression, malnutrition, psychological stress, smoking, and tissue trauma.

B. vincentii doesn’t act alone but typically causes infection in partnership with other bacteria, particularly Fusobacterium species. This synergistic relationship between spirochetes and fusiform bacilli creates what’s known as the fusospirochetal complex.

Vincent’s stomatitis and acute necrotizing ulcerative gingivitis 🔗

The primary disease associated with B. vincentii is Vincent’s stomatitis, also called acute necrotizing ulcerative gingivitis or ANUG. This condition gained the colloquial name “trench mouth” because it was common among soldiers during World War I, likely due to stress, poor nutrition, and inadequate oral hygiene in battlefield conditions.

Patients with ANUG present with painful, swollen, bleeding gums and characteristic “punched-out” ulcerations at the gingival margins and between teeth. The infection produces a distinctive fetid breath odor that often alerts healthcare providers to the diagnosis. Small, painful ulcers may spread from the gums to involve the throat and tonsils in severe cases.

The condition typically affects adolescents and young adults, though it can occur at any age. Systemic symptoms like fever and general malaise may accompany the local oral manifestations, particularly in more severe cases or in immunocompromised individuals.

Diagnosis and management 🔗

Diagnosis of B. vincentii infections relies primarily on clinical presentation combined with microscopic examination. Direct microscopy of smears taken from lesions typically reveals the characteristic fusospirochetal complex. Unlike B. recurrentis, culturing B. vincentii is challenging due to its anaerobic nature and the complexity of the oral microbiota.

Treatment involves a multi-pronged approach. Antimicrobial therapy, typically with metronidazole or penicillin, targets both the spirochetes and anaerobic bacteria. Gentle but thorough oral care helps remove debris and plaque. Pain management and maintaining adequate nutrition and hydration support recovery. Most importantly, addressing underlying factors like improving nutrition, managing stress, and promoting smoking cessation helps prevent recurrence.

Prevention and control strategies 🔗

Controlling Borrelia infections requires different approaches depending on the species. For epidemic relapsing fever, prevention focuses on interrupting louse transmission. This includes improving access to personal hygiene facilities, washing infested clothing in hot water above 130°F, and treating active louse infestations with appropriate pediculicides.

During outbreaks, mass delousing programs have proven effective. Simple measures like bagging potentially infested clothing away from individuals for 7-10 days can kill lice through starvation, as they require regular blood meals to survive.

For B. vincentii infections, prevention centers on maintaining good oral hygiene through regular tooth brushing, professional dental care, and addressing risk factors like smoking and malnutrition. Early recognition and treatment prevent progression to more severe forms of necrotizing periodontal disease.

Clinical significance for healthcare providers 🔗

Understanding Borrelia species is crucial for healthcare professionals for several reasons. First, relapsing fever can mimic other periodic fever syndromes like malaria, typhoid, or leptospirosis, making accurate diagnosis essential. Travel history and exposure information become critical diagnostic clues.

Second, treatment of relapsing fever requires careful monitoring. A significant proportion of patients develop Jarisch-Herxheimer reaction after starting antibiotics, characterized by fever, chills, hypotension, and other flu-like symptoms caused by bacterial lysis releasing inflammatory contents. While rarely fatal, this reaction requires supportive care and patient observation.

Third, recognizing the mixed bacterial nature of Vincent’s stomatitis guides appropriate antimicrobial selection and comprehensive treatment planning. Simply prescribing antibiotics without addressing oral hygiene and underlying risk factors often leads to treatment failure or recurrence.

What do you think? How might understanding the unique antigenic variation strategy of Borrelia bacteria inform development of future vaccines or treatments? What role does patient education play in preventing both epidemic relapsing fever in high-risk populations and oral infections like Vincent’s stomatitis in clinical practice?

References

1. https://www.ncbi.nlm.nih.gov/books/NBK441913/
2. https://www.cdc.gov/relapsing-fever/about/about-lbrf.html
3. https://www.britannica.com/science/Vincent-gingivitis